前往化源商城

Current Opinion in Organ Transplantation 2014-04-01

Strategies to prevent the neuropsychiatric side-effects of corticosteroids: a case report and review of the literature.

Stephen West, Chris Kenedi

文献索引:Curr. Opin. Organ Transplant. 19(2) , 201-8, (2014)

全文:HTML全文

摘要

The use of corticosteroids is increasing, and while the physical complications of their use are well known, the neuropsychiatric consequences are not. This review focuses on preventing these neuropsychiatric complications. Although there are limited data on this subject, it is a problem that clinicians face on a regular basis.The incidence of neuropsychiatric complications rises rapidly once the daily dose of prednisone is greater than 40 mg. Other risk factors for neuropsychiatric symptoms are damaged blood-brain barrier and hypoalbuminemia. All patients receiving corticosteroids and their caregivers should be warned about the potential neuropsychiatric complications. Small trials have supported the use of various agents as prophylaxis. The development of neuropsychiatric symptoms secondary to corticosteroids should lead to prompt involvement of liaison psychiatry.There is a lack of large randomized controlled studies to inform clinical practice. At present, lithium and olanzapine probably represent the best choices for prophylaxis. Patients with a prior history of steroid-related psychosis or mania should be considered for prophylaxis when future courses of steroids are prescribed as limited data, and our clinical experience suggests that this can reduce the future episodes of neuropsychiatric side-effects.

相关化合物

结构式 名称/CAS号 全部文献
泼尼松 结构式 泼尼松
CAS:53-03-2
4-氨基丁酸 结构式 4-氨基丁酸
CAS:56-12-2
甲基泼尼松龙 结构式 甲基泼尼松龙
CAS:83-43-2
奥氮平 结构式 奥氮平
CAS:132539-06-1
劳拉西泮 结构式 劳拉西泮
CAS:846-49-1
加巴喷丁 结构式 加巴喷丁
CAS:60142-96-3
4,4-五亚甲基-2-吡咯烷酮 结构式 4,4-五亚甲基-2-吡咯烷酮
CAS:64744-50-9